NEWS6 December 2012

Pharma veteran Denysyk takes helm at HRA

North America People

US — Healthcare Research & Analytics (HRA) has appointed Oleh Denysyk as its new president, replacing John Maglione who is taking an as yet unspecified new role within the company, according to a statement.

Denysyk (pictured) was formerly a consultant for Pharmaceutical Intelligence. Before that he was an analytics and strategy director for Roche Pharmaceuticals and strategic marketing research director for Pfizer Pharmaceuticals. Earlier in his career he worked for Sanofi-Aventis and Novartis.

HRA parent company MJH & Associates said it was “very fortunate to welcome Oleh as president of HRA, as he brings a distinguished career and leadership in our industry”.

Maglione, Denysyk’s predecessor, has been with HRA for less than two years. MJH’s chief operating officer Tighe Blazier said: “We acknowledge John for his service to HRA and look forward to his continued contribution to our company.”